OGN vs RPAY · P/E 3.4, rev $3.02B vs rev $181.5M
Organon & Co (OGN) versus Repay Holdings Corp (RPAY) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Repay Holdings Corp (RPAY) is a software - infrastructure company listed on NASDAQ.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported RPAY revenue for 2026-06-30 was $181.5M. Net income was -$20.9M. RPAY currently screens at market cap $292.4M.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. RPAY currently screens at market cap $292.4M.
Not investment advice. Open the OGN and RPAY stock pages for the full models.
Not investment advice.